Literature DB >> 7392529

[Renal osteodystrophy in children. Therapy with 1,25-dihydroxy-cholechalciferol (author's transl)].

M Bulla, G Delling, G Benz-Bohm, G J Stock, A Sánchez de Reutter, R Ziegler, H Lühmann, M Severin, E Kalbitzer, C Manegold.   

Abstract

Growth arrest and renal osteodystrophy are major problems in renal insufficiency of children. The present report describes our experiences in managing renal osteodystrophy in 14 dialyzed children using 1,25-DHCC for 12 months. Values in plasma of Ca, P, Mg, alkaline phosphatase, iPTH, 25-OH-D, and 1,25-DHCC were determined regulary. Skeletal X-rays and analysis of iliac crest biopsies were obtained in each child. In treatment with 1,25-DHCC episodes of severe but reversible hypercalcemia occurred. Alkaline phosphatase and iPTH normalized completely. Radiographic examinations revealed marked improvement. Histological signs of fibro-osteoclasia and resorptive defects disappeared but there was no recovery of osteomalacia. A reduction of osteoblast population and of bone transformation was obvious. 1,25-DHCC failed to normalize growth in uremic children. In short, neither vitamin D nor 1,25-DHCC can guarantee complete recovery of renal osteodystrophy and growth arrest in uremic children.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7392529     DOI: 10.1007/bf01477068

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  37 in total

1.  [Therapy of growth disorders in chronic kidney insufficiency].

Authors:  G Gilli
Journal:  Monatsschr Kinderheilkd       Date:  1975-12

2.  1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.

Authors:  S Balsan; M Garabedian; R Sorgniard; M F Holick; H F Deluca
Journal:  Pediatr Res       Date:  1975-07       Impact factor: 3.756

3.  1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.

Authors:  T Berl; A S Berns; W E Hufer; K Hammill; A C Alfrey; C D Arnaud; R W Schrier
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

4.  Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy.

Authors:  R W Chesney; A V Moorthy; J A Eisman; D K Jax; R B Mazess; H F DeLuca
Journal:  N Engl J Med       Date:  1978-02-02       Impact factor: 91.245

5.  Bone disease in children with chronic renal failure: therapy with 1alpha-hydroxyvitamin D3.

Authors:  R J Postlethwaite; I B Houston
Journal:  Clin Endocrinol (Oxf)       Date:  1977-12       Impact factor: 3.478

Review 6.  Growth in renal failure.

Authors:  O Mehls; E Ritz; G Gilli; W Kreusser
Journal:  Nephron       Date:  1978       Impact factor: 2.847

Review 7.  Growth in children with renal disease with particular reference to the effects of calorie malnutrition: a review.

Authors:  M A Holliday
Journal:  Clin Nephrol       Date:  1973 Jul-Aug       Impact factor: 0.975

8.  [Dialysis bone disease in children. Six cases (author's transl)].

Authors:  J C Luciani; J L Ferran; M L Dumas; P Meunier; R Dumas
Journal:  Nouv Presse Med       Date:  1977-11-19

9.  [Calcium phosphate metabolism during therapy with 1,25-dihydroxycholecalciferol [1,25 DHCC (Ro 21/5535)] in patients with advanced kidney insufficiency].

Authors:  W Schulz; P Spiegel; U Gessler; G Delling
Journal:  Verh Dtsch Ges Inn Med       Date:  1978

10.  Carboxyl-terminal fragments of human parathyroid hormone in parathyroid tumors: unique new source of immunogens for the production of antisera potentially useful in the radioimmunoassay of parathyroid hormone in human serum.

Authors:  F P Di Bella; J B Gilkinson; J Flueck; C D Arnaud
Journal:  J Clin Endocrinol Metab       Date:  1978-04       Impact factor: 5.958

View more
  1 in total

Review 1.  Recent advances and controversies in childhood renal osteodystrophy.

Authors:  O Mehls; I B Salusky
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.